Weighing the adverse cardiac effects of fluoroquinolones: A risk perspective

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 91-2700, Iss. 11, 2015-11 ,pp. : 1198-1206

John Wiley & Sons Inc

Access to resources Recommend Favorite

In Silico Assessment of Adverse Effects of a Large Set of 6-Fluoroquinolones Obtained from a Study of Tuberculosis Chemotherapy

By  

Current Drug Safety, Vol. 7, Iss. 4, 2012-09 ,pp. : 313-320

Bentham Science Publishers

Access to resources Recommend Favorite

Obesity as a risk factor for Alzheimer's disease: weighing the evidence

By  

OBESITY REVIEWS, Vol. 19, Iss. 2, 2018-02 ,pp. : 269-280

John Wiley & Sons Inc

Access to resources Recommend Favorite

Role of N-terminal pro B-type natriuretic peptide in identifying patients at high risk for adverse outcome after emergent non-cardiac surgery

By Farzi S.   Stojakovic T.   Marko Th.   Sankin C.   Rehak P.   Gumpert R.   Baumann A.   Höfler B.   Metzler H.   Mahla E.   Hemmings H. C.  

BJA: British Journal of Anaesthesia, Vol. 110, Iss. 4, 2013-04 ,pp. : 554-560

Oxford University Press

Access to resources Recommend Favorite

Routine weighing of women during pregnancy is of limited value and should be abandoned: AGAINST: Routine weighing in pregnancy is the first step to preventing adverse birth outcomes

By  

BJOG : AN INTERNATIONAL JOURNAL OF OBSTETRICS & GYNAECOLOGY, Vol. 122, Iss. 8, 2015-07 ,pp. : 1101-1101

John Wiley & Sons Inc

Access to resources Recommend Favorite